|
Letter from the CEO
| |
Improving the Human Condition
By D. Todd Dollinger, CEO and Co-Chairman of The Trendlines Group
"Creating and developing businesses to improve the human condition" is a bold statement. This is not a tagline, however, it's our mission.
We work toward fulfilling our mission every day -- through the companies we create, the businesses we develop, the entrepreneurs we work with, the investors with whom we partner, and even through our participation in conferences and events we organize. Read more
|
|
Latest News from The Trendlines Group
|
Did We See You on the 2012 Trendlines U.S. Road Show?
The Trendlines Group organized, with the help of our gracious local partners, an investor road show that  showcased 13 of our portfolio companies. More than 400 people interacted with our company CEOs, who presented their innovative technology to investors in each city.
Read the article about the road show in the Chicago Tribune, take a look through our Road Show photo album, or watch the video on YouTube.
Do you want to learn more about the companies featured on the 2012 Road Show? Or be in touch with the CEOs you met? Check out our web site for links to all 13 companies.
Mofet's Debut at AgriVest 2012 and Agritech 2012
 Nine months ago, our Mofet Venture Accelerator embarked on an expeditious journey: Repositioning Mofet as the only technological incubator in Israel specializing in agritech and food. On May 14, Mofet formally kicked off its new focus as the co-organizers of the 2012 AgriVest Summit. More than 150 attendees met at Mikveh Israel in Holon to hear presentations by Israel's leading policy makers on agriculture, as well as internationally-renowned experts in the area of investing in agriculture.
From May 15 to May 17, Mofet displayed the incubator's seed-stage agritech companies and met with industry professionals and entrepreneurs. See our photo album from the event and from Mofet's booth at Agritech 2012.
Todd Dollinger to Address AICC, Southeast Region
On June 5, Todd will be in Memphis, Tennessee to address the American-Israel Chamber of Commerce, SE region on the topic of "Growing Life Sciences Companies."
10 Groups Visit Trendlines' Misgav Headquarters
The Trendlines Group and Misgav Venture Accelerator are pleased to host groups touring Israel and share our "start up nation" story. Whether our guests are visiting dignitaries from Africa, reporters from Korea, students from the United States, Jewish Federation mission participants, Israeli soldiers, or tourists, we love opening our doors, showing off our facilities, and introducing visitors to our work and mission.
 | |
Steve Rhodes Meets with Israeli Soldiers Visiting Our Office
|
Todd Dollinger Presents at the 2012 International Medical Device Forum in Shanghai
In May, Todd Dollinger traveled to Shanghai, China as a featured speaker at the 2012 International Medical Device Forum. Addressing a crowd of more than 200 people, Todd shared the Trendlines mission and spoke on the topic of "Business Incubation: The Israel Model and Trendlines' Experience."
 | |
Todd Dollinger Presents at the Forum in Shanghai
|
|
|
|
In January 2012, Sol Chip raised $300,000 from angel investors. As well, the Israel Electric Company has expressed interest in Sol Chip's technology and is considering an investment. Read more in the most recent issue of Mofet's newsletter.
NovoSpeech Raises $100,000; Completes Core Development NovoSpeech announced that a current investor, the Maryland/Israel Trendlines Fund, has committed $100,000 to the company. NovoSpeech is currently raising $500,000 to accelerate time-to-market for its next product. Read more in the most recent issue of Mofet's newsletter. Juvenis Receives $1 Million Investment from Syneron
Juvenis recently announced a $1 million raise from Syneron Medical (Nasdaq: ELOS). Juvenis is developing Tenergel™, a safe, biodegradable dermal filler with applications in aesthetic and body contouring procedures. Read more in the latest newsletter from Misgav Venture Accelerator. |
|
News from Our Portfolio Companies
|
Stimatix Announces FDA Registration and Device Listing for Its AOS-C2000™
Stimatix GI Ltd., a leading developer of low-profile solutions for colostomy management, announced it has completed FDA registration and device listing for its AOS-C2000™ as part of its commercial distribution plans in the U.S. In parallel, filing of the AOS-C2000™ in the European Union for obtaining the CE mark is expected shortly. The filing activities are to be followed by post marketing surveillance, aiming at product readiness to market in the EU by the end of the year. Stimatix GI is developing the AOS-C1000™ and the AOS-C2000™ as part of its colostomy product line that provides voluntary bowel evacuation and improves the quality of life for people with a stoma.
Virtual Ports Launches EndoGrab in Japan
 | |
Senko's EndoGrab Booth
|
Virtual Ports' Japanese distributor/partner, Senko, formally launched the EndoGrab during the annual meeting of the Japan Surgery Society (JSS) in May. EndoGrab was featured at the Senko booth and was also introduced in a special evening presentation on Reduced Ports Surgery to over 150 participants, notes Dan Shwarzman, CEO of Virtual Ports. "This launch came after more than a year of thorough preparations on Senko side," says Shwarzman, "and a controlled release to a few leading surgeons in Japan. We have high expectations from the growing laparoscopic market in Japan and have confidence in Senko's ability to maximize its potential."
Achievements from Our Public Companies
- ETView received Health Canada license for the marketing of its VivaSight™ DL, the world's only single-use double-lumen airway tube with an integrated high-resolution camera. Approval for U.S. and European marketing are imminent; the company submitted FDA filing for VivaSight, as well.
- FlowSense signed a cooperation agreement with Philips in December.
ApiFix Announces First Implantation in Humans
ApiFix Ltd., developer of a system to correct Adolescent Idiopathic Scoliosis (AIS), announced last week that the company accomplished its first successful implantation of its minimally invasive scoliosis correction system in human. ApiFix also was the subject of a recent Israel 21c article, "Scoliosis Solution." As a result of the article, says founder and CEO Uri Arnin, ApiFix receives at least one email a day requesting more information.
|
|
Staff News
| |
Welcome to Vladimir Yakhlial, Model & Concept Developer, Trendlines Labs
Welcome to Vladimir Yakhlial, who joined the Trendlines Labs team last month.
|
|
|
|
|
|
Watch Trendlines
on YouTube
|
|
|
Visit Misgav Venture Accelerator at ILSI-Biomed
|
Misgav Venture Accelerator will be at ILSI-Biomed this week, May 21-23. Visit us at Booth #43.
|
|
New Trendlines Portfolio Companies
|
Welcome to our newest Mofet Venture Accelerator companies: MiRobot, CattleSense, and EdenShield.
|
|
|
